Alzheimer's Early Detection with Personalized Brain Health Planning
Statistics show that some people in their 40s and 50s may have presymptomatic Alzheimer's disease. As many as 6.9% of all cases are now found in younger individuals, most of whom are of working age.
Alzheimer’s disease—the most common cause of dementia—accounts for approximately 70% of dementia cases.
With Samitivej's P-tau blood test for preclinical Alzheimer’s disease:
- Pre-diagnosis can be made up to 10 years in advance
- Accuracy is up to 86–88%* (area under the ROC curve)
- Testing is simple and safe, with results available within 90 days
*ROC: Receiver Operating Characteristic
Alzheimer’s disease, the most common cause of dementia, can be detected years before symptoms appear. In the past, this required a PET scan or a lumbar puncture to collect cerebrospinal fluid to test for disease-related proteins. In recent years, however, technology has been developed to detect these proteins through a blood test, something previously not possible with conventional technology. This makes testing easier and less invasive for patients.
Who is this program suitable for?
- Individuals experiencing memory problems that interfere with daily life, such as increasing difficulty understanding what they read, making frequent errors in judgment, changes in mood or personality, or confusion about the date or time
- Individuals aged 40 and above who are concerned about or would like to understand their risk over the next 10-15 years in order to take a more proactive approach to their health
- Individuals aged 60 and above
- Individuals with a family member or first-degree relative with dementia
| Program | Promotional Price (THB) |
| P-Tau Blood Test and APOE Genotyping, with Personalized Brain Health Planning | 11,000 |
| P-Tau Blood Test, APOE Genotyping and Brain MRI, with Personalized Brain Health Planning | 22,000 |
